Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cerilliant
Dow
Farmers Insurance
US Department of Justice
Julphar
Federal Trade Commission
Accenture
Johnson and Johnson

Generated: December 18, 2018

DrugPatentWatch Database Preview

Drug Sales Trends for DIAZEPAM

« Back to Dashboard

Payment Methods and Pharmacy Types for DIAZEPAM (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $7,141,131
INSIDE ANOTHER STORE $32,206,608
[disabled in preview] $83,732,460
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 475,780
INSIDE ANOTHER STORE 1,580,385
[disabled in preview] 4,528,815
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $13,575,299
MEDICARE $44,446,574
[disabled in preview] $65,058,328
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for DIAZEPAM
Drug Units Sold Trends for DIAZEPAM

Annual Sales Revenues and Units Sold for DIAZEPAM

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
DIAZEPAM ➤ Sign Up ➤ Sign Up 2016
DIAZEPAM ➤ Sign Up ➤ Sign Up 2015
DIAZEPAM ➤ Sign Up ➤ Sign Up 2014
DIAZEPAM ➤ Sign Up ➤ Sign Up 2013
DIAZEPAM ➤ Sign Up ➤ Sign Up 2012
DIAZEPAM ➤ Sign Up ➤ Sign Up 2011
DIAZEPAM ➤ Sign Up ➤ Sign Up 2010
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Cerilliant
AstraZeneca
Baxter
Johnson and Johnson
Cipla
Boehringer Ingelheim
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.